Get App Open
In App
Lending
Lending
Open App
you are here:

JB Chemicals and Pharmaceuticals Ltd.

BSE: 506943 | NSE: JBCHEPHARM |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE572A01036 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Oct 24, 15:07
1701.00 -5.90 (-0.35%)
Volume
AVERAGE VOLUME
5-Day
7,103
10-Day
4,498
30-Day
2,665
814
  • Prev. Close

    1706.90

  • Open Price

    1724.00

  • Bid Price (Qty.)

    1703.30 (5)

  • Offer Price (Qty.)

    1704.95 (3)

NSE Live

Oct 24, 15:07
1703.50 -5.30 (-0.31%)
Volume
AVERAGE VOLUME
5-Day
112,729
10-Day
136,785
30-Day
146,946
85,625
  • Prev. Close

    1708.80

  • Open Price

    1721.50

  • Bid Price (Qty.)

    1703.10 (3)

  • Offer Price (Qty.)

    1703.20 (1)

Financials

Balance Sheet of JB Chemicals and Pharmaceuticals (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
EQUITIES AND LIABILITIES  
SHAREHOLDER'S FUNDS  
Equity Share Capital 15.46 16.05 16.71 16.96 16.96  
Total Share Capital 15.46 16.05 16.71 16.96 16.96  
Reserves and Surplus 1,429.83 1,468.52 1,436.67 1,370.90 1,205.74  
Total Reserves and Surplus 1,429.83 1,468.52 1,436.67 1,370.90 1,205.74  
Total Shareholders Funds 1,445.29 1,484.56 1,453.39 1,387.86 1,222.71  
NON-CURRENT LIABILITIES  
Long Term Borrowings 0.00 0.00 0.00 0.00 0.00  
Deferred Tax Liabilities [Net] 58.85 71.15 49.70 28.95 32.07  
Other Long Term Liabilities 7.06 2.20 3.60 3.95 3.81  
Long Term Provisions 7.39 5.73 9.67 8.88 10.20  
Total Non-Current Liabilities 73.29 79.08 62.98 41.79 46.07  
CURRENT LIABILITIES  
Short Term Borrowings 32.04 25.80 28.48 48.86 174.40  
Trade Payables 111.35 76.71 100.22 79.03 68.61  
Other Current Liabilities 144.31 124.62 112.68 118.95 123.32  
Short Term Provisions 4.73 1.34 8.91 7.87 6.23  
Total Current Liabilities 292.43 228.47 250.29 254.72 372.56  
Total Capital And Liabilities 1,811.01 1,792.12 1,766.66 1,684.37 1,641.33  
ASSETS  
NON-CURRENT ASSETS  
Tangible Assets 565.33 542.54 559.94 593.67 367.97  
Intangible Assets 17.87 9.57 9.97 15.02 1.38  
Capital Work-In-Progress 16.17 15.09 17.40 3.76 134.19  
Other Assets 0.00 0.00 0.00 0.00 0.00  
Fixed Assets 599.37 567.20 587.31 612.45 504.24  
Non-Current Investments 202.42 228.84 182.92 318.81 364.38  
Deferred Tax Assets [Net] 0.00 0.00 0.00 0.00 0.00  
Long Term Loans And Advances 0.28 3.59 3.33 3.29 0.15  
Other Non-Current Assets 3.67 5.94 7.70 6.81 22.81  
Total Non-Current Assets 805.74 805.57 781.26 941.36 891.59  
CURRENT ASSETS  
Current Investments 333.81 360.65 383.77 224.96 247.28  
Inventories 232.04 208.10 175.81 159.96 133.29  
Trade Receivables 344.24 300.92 300.54 265.10 265.67  
Cash And Cash Equivalents 11.56 20.77 14.95 7.20 10.71  
Short Term Loans And Advances 4.02 0.71 0.21 0.44 0.57  
OtherCurrentAssets 79.60 95.39 110.11 85.36 92.23  
Total Current Assets 1,005.27 986.55 985.39 743.01 749.75  
Total Assets 1,811.01 1,792.12 1,766.66 1,684.37 1,641.33  
OTHER ADDITIONAL INFORMATION  
CONTINGENT LIABILITIES, COMMITMENTS  
Contingent Liabilities 121.66 86.45 173.76 68.37 91.92  
CIF VALUE OF IMPORTS  
Raw Materials 0.00 0.00 0.00 0.00 65.35  
Stores, Spares And Loose Tools 0.00 0.00 0.00 0.00 0.00  
Trade/Other Goods 0.00 0.00 0.00 0.00 0.00  
Capital Goods 0.00 0.00 0.00 0.00 21.16  
EXPENDITURE IN FOREIGN EXCHANGE  
Expenditure In Foreign Currency 215.30 192.31 616.39 133.44 39.64  
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS  
Dividend Remittance In Foreign Currency -- -- -- -- 0.76  
EARNINGS IN FOREIGN EXCHANGE  
FOB Value Of Goods -- -- -- -- 611.49  
Other Earnings 781.45 792.00 -- -- 5.41  
BONUS DETAILS  
Bonus Equity Share Capital 8.46 8.78 9.14 9.28 9.28  
NON-CURRENT INVESTMENTS  
Non-Current Investments Quoted Market Value 56.57 83.84 39.86 176.81 223.45  
Non-Current Investments Unquoted Book Value 145.85 145.00 143.07 142.00 140.93  
CURRENT INVESTMENTS  
Current Investments Quoted Market Value 333.81 360.65 383.77 224.96 247.28  
Current Investments Unquoted Book Value -- -- -- -- --  
Source : Dion Global Solutions Limited